FIELD: medicine.
SUBSTANCE: invention relates to composition as an aqueous solution no containing human serum albumin. α-Interferon composition as an aqueous solution comprises α-interferon, stabilizing agent, agent regulating osmotic pressure, antibacterial preserving agents taken among the group consisting of phenol, m-cresol or their mixtures, and buffer system. The composition retains α-interferon activity for a long time, eliminates the potential danger for human body by minimizing amount of preserving agents and exhibits high stability.
EFFECT: valuable properties of composition.
7 cl, 13 tbl, 41 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS OF ERYTHROPOIETIN | 2000 |
|
RU2225221C2 |
| COMPOSITION OF AQUEOUS SOLUTION OF RECOMBINANT HUMAN INTERFERON ALPHA-2 FOR RECTAL ADMINISTRATION | 2014 |
|
RU2564951C1 |
| LIQUID FORMULATION OF LONG-ACTING INSULIN CONJUGATE | 2013 |
|
RU2670270C2 |
| PREPARATIVE FORM OF STABLE AQUEOUS SOLUTION OF INTERFERON, METHOD FOR ITS PREPARING AND USING | 2000 |
|
RU2242242C2 |
| ALPHA-INTERFERON PREPARATIONS AS STABLE AQUEOUS SOLUTION | 1995 |
|
RU2157236C2 |
| HUMAN INTERFERON-ALPHA-TWO AQUEOUS SOLUTION FOR INJECTION | 2002 |
|
RU2238758C2 |
| SOLUTION FOR INJECTION, RECOMBINANT PLASMID DNA pSX50 ENCODING SYNTHESIS OF HUMAN RECOMBINANT ALPHA-2b INTERFERON, STRAIN Escherichia coli SX50 AS INDUSTRIAL STRAIN-PRODUCER OF HUMAN RECOMBINANT ALPHA-2b INTERFERON AND METHOD FOR INDUSTRIAL PREPARING INTERFERON ALPHA-2b | 2006 |
|
RU2319502C1 |
| LIQUID FORMULATION OF LONG-ACTING INSULINOTROPIC PEPTIDE CONJUGATE | 2013 |
|
RU2671576C2 |
| STABLE PHARMACEUTICAL PREPARATION BASED ON THE PD-1 ANTIBODY AND ITS USE IN MEDICINE | 2016 |
|
RU2731418C2 |
| ALPHA-INTERFERON PREPARATION IN THE FORM OF STABLE AQUEOUS SOLUTION FOR INJECTIONS | 2004 |
|
RU2255729C1 |
